MedTrace Logo

To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome

NCT05941650 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-02-05

No results posted yet for this study

Summary

To evaluate whether there is clinical improvement through the scales (Bristol, IBS severity score, and IBS quality of life) in women with irritable bowel syndrome after administration of SC-FOS (short-chain fructooligosaccharides).

Conditions

  • Irritable Bowel Syndrome
  • Diarrhea- Irritable Bowel Syndrome
  • Constipation-predominant Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Short Chain Fructooligosaccharides

The intervention will receive Short-Chain Fructooligosaccharides at a dose of 12 gr. every 24 hours diluted in 250 ml of water.

OTHER

Corn Starch

This group will receive 12 g of corn starch as a control group.

Sponsors & Collaborators

  • Universidad Autonoma de Chihuahua

    lead OTHER

Principal Investigators

  • Luis B Enríquez Sánchez · Universidad Autonoma de Chihuahua

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-02
Primary Completion
2025-05-10
Completion
2025-05-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05941650 on ClinicalTrials.gov